| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.51 | 0.0009 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.003 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |